• Matthias Müller
  • Nicole Avitahl-Curtis
Part of the Progress in Inflammation Research book series (PIR)


Bacterial Artificial Chromosome Experimental Autoimmune Encephalomyelitis Enhance Green Fluorescent Protein Internal Ribosomal Entry Site Endothelial Cell Activation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Zambrowicz BP, Sands AT (2003) Knockouts model the 100 best-selling drugs — will they model the next 100? Nat Rev Drug Discov 2: 38–51PubMedCrossRefGoogle Scholar
  2. 2.
    Nagy A, Gertsenstein M, Vintersten K, Behringer R (2002) Manipulating the Mouse Embryo: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring HarborGoogle Scholar
  3. 3.
    Wolfer DP, Crusio WE, Lipp HP (2002) Knockout mice: simple solutions to the problems of genetic background and flanking genes. Trends Neurosci 25: 336–340PubMedCrossRefGoogle Scholar
  4. 4.
    Schonig K, Schwenk F, Rajewsky K, Bujard H (2002) Stringent doxycycline dependent control of CRE recombinase in vivo. Nucleic Acids Res 30: e134PubMedCrossRefGoogle Scholar
  5. 5.
    Copeland NG, Jenkins NA, Court DL (2001) Recombineering: a powerful new tool for mouse functional genomics. Nat Rev Genet 2: 769–779PubMedCrossRefGoogle Scholar
  6. 6.
    Yang Y, Seed B (2003) Site-specific gene targeting in mouse embryonic stem cells with intact bacterial artificial chromosomes. Nat Biotechnol 21: 447–451PubMedCrossRefGoogle Scholar
  7. 7.
    Branda CS, Dymecki SM (2004) Talking about a revolution: The impact of site-specific recombinases on genetic analyses in mice. Dev Cell 6: 7–28PubMedCrossRefGoogle Scholar
  8. 8.
    Sauer B, Henderson N (1988) Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc Natl Acad Sci USA 85: 5166–5170PubMedCrossRefGoogle Scholar
  9. 9.
    Cox MM (1983) The FLP protein of the yeast 2-microns plasmid: expression of a eukaryotic genetic recombination system in Escherichia coli. Proc Natl Acad Sci USA 80: 4223–4227PubMedCrossRefGoogle Scholar
  10. 10.
    Korfhagen TR, Swantz RJ, Wert SE, McCarty JM, Kerlakian CB, Glasser SW, Whitsett JA (1994) Respiratory epithelial cell expression of human transforming growth factor-alpha induces lung fibrosis in transgenic mice. J Clin Invest 93: 1691–1699PubMedGoogle Scholar
  11. 11.
    Elias JA, Zhu Z, Chupp G, Homer RJ (1999) Airway remodeling in asthma. J Clin Invest 104: 1001–1006PubMedGoogle Scholar
  12. 12.
    Toniatti C, Bujard H, Cortese R, Ciliberto G (2004) Gene therapy progress and prospects: transcription regulatory systems. Gene Ther 11: 649–657PubMedCrossRefGoogle Scholar
  13. 13.
    Ryding AD, Sharp MG, Mullins JJ (2001) Conditional transgenic technologies. J Endocrinol 171: 1–14PubMedCrossRefGoogle Scholar
  14. 14.
    Seibler J, Zevnik B, Kuter-Luks B, Andreas S, Kern H, Hennek T, Rode A, Heimann C, Faust N, Kauselmann G et al (2003) Rapid generation of inducible mouse mutants. Nucleic Acids Res 31: e12PubMedCrossRefGoogle Scholar
  15. 15.
    Weber W, Rimann M, Spielmann M, Keller B, Daoud-El Baba M, Aubel D, Weber CC, Fussenegger M (2004) Gas-inducible transgene expression in mammalian cells and mice. Nat Biotechnol 22: 1440–1444PubMedCrossRefGoogle Scholar
  16. 16.
    Baer A, Bode J (2001) Coping with kinetic and thermodynamic barriers: RMCE, an efficient strategy for the targeted integration of transgenes. Curr Opin Biotechnol 12: 473–480PubMedCrossRefGoogle Scholar
  17. 17.
    Shmerling D, Danzer C, Mao X, Boisclair J, Haffner M, Lemaistre M, Schuler V, Kaeslin E, Korn R, Bürki K et al (2005) Strong and ubiquitous expression of transgenes targeted into the beta-actin locus by Cre/lox cassette replacement. Genesis 42: 229–235PubMedCrossRefGoogle Scholar
  18. 18.
    Mittal V (2004) Improving the efficiency of RNA interference in mammals. Nat Rev Genet 5: 355–365PubMedCrossRefGoogle Scholar
  19. 19.
    Oberdoerffer P, Kanellopoulou C, Heissmeyer V, Paeper C, Borowski C, Aifantis I, Rao A, Rajewsky K (2005) Efficiency of RNA interference in the mouse hematopoietic system varies between cell types and developmental stages. Mol Cell Biol 25: 3896–3905PubMedCrossRefGoogle Scholar
  20. 20.
    Seibler J, Kuter-Luks B, Kern H, Streu S, Plum L, Mauer J, Kuhn R, Bruning JC, Schwenk F (2005) Single copy shRNA configuration for ubiquitous gene knockdown in mice. Nucleic Acids Res 33: e67PubMedCrossRefGoogle Scholar
  21. 21.
    Eggan K, Akutsu H, Loring J, Jackson-Grusby L, Klemm M, Rideout WM 3rd, Yanagimachi R, Jaenisch R (2001) Hybrid vigor, fetal overgrowth, and viability of mice derived by nuclear cloning and tetraploid embryo complementation. Proc Natl Acad Sci USA 98: 6209–6214PubMedCrossRefGoogle Scholar
  22. 22.
    Shah K, Jacobs A, Breakefield XO, Weissleder R (2004) Molecular imaging of gene therapy for cancer. Gene Ther 11: 1175–1187PubMedCrossRefGoogle Scholar
  23. 23.
    Ntziachristos V, Ripoll J, Wang LV, Weissleder R (2005) Looking and listening to light: the evolution of whole-body photonic imaging. Nat Biotechnol 23: 313–230PubMedCrossRefGoogle Scholar
  24. 24.
    Kouskoff V, Korganow AS, Duchatelle V, Degott C, Benoist C, Mathis D (1996) Organ-specific disease provoked by systemic autoimmunity. Cell 87: 811–822PubMedCrossRefGoogle Scholar
  25. 25.
    Kouskoff V, Korganow AS, Duchatelle V, Degott C, Benoist C, Mathis D (1997) A new mouse model of rheumatoid arthritis: organ-specific disease provoked by systemic autoimmunity. Ryumachi 37: 147PubMedGoogle Scholar
  26. 26.
    Matsumoto I, Staub A, Benoist C, Mathis D (1999) Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science 286: 1732–1735PubMedCrossRefGoogle Scholar
  27. 27.
    Ji H, Gauguier D, Ohmura K, Gonzalez A, Duchatelle V, Danoy P, Garchon HJ, Degott C, Lathrop M, Benoist C et al (2001) Genetic influences on the end-stage effector phase of arthritis. J Exp Med 194: 321–330PubMedCrossRefGoogle Scholar
  28. 28.
    Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G (1999) Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 10: 387–398PubMedCrossRefGoogle Scholar
  29. 29.
    Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I (1993) Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75: 253–261PubMedCrossRefGoogle Scholar
  30. 30.
    Gaetke LM, Oz HS, Frederich RC, McClain CJ (2003) Anti-TNF-alpha antibody normalizes serum leptin in IL-2 deficient mice. J Am Coll Nutr 22: 415–420PubMedGoogle Scholar
  31. 31.
    Baumgart DC, Olivier WA, Reya T, Peritt D, Rombeau JL, Carding SR (1998) Mechanisms of intestinal epithelial cell injury and colitis in interleukin 2 (IL2)-deficient mice. Cell Immunol 187: 52–66PubMedCrossRefGoogle Scholar
  32. 32.
    Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263–274PubMedCrossRefGoogle Scholar
  33. 33.
    Davidson NJ, Leach MW, Fort MM, Thompson-Snipes L, Kuhn R, Muller W, Berg DJ, Rennick DM (1996) T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J Exp Med 184: 241–251PubMedCrossRefGoogle Scholar
  34. 34.
    Sligh JE Jr, Ballantyne CM, Rich SS, Hawkins HK, Smith CW, Bradley A, Beaudet AL (1993) Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. Proc Natl Acad Sci USA 90: 8529–8533PubMedCrossRefGoogle Scholar
  35. 35.
    Hata H, Sakaguchi N, Yoshitomi H, Iwakura Y, Sekikawa K, Azuma Y, Kanai C, Moriizumi E, Nomura T, Nakamura T et al (2004) Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice. J Clin Invest 114: 582–588PubMedCrossRefGoogle Scholar
  36. 36.
    Neurath MF, Fuss I, Pasparakis M, Alexopoulou L, Haralambous S, Meyer zum Buschenfelde KH, Strober W, Kollias G (1997) Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. Eur J Immunol 27: 1743–1750PubMedGoogle Scholar
  37. 37.
    Campbell IK, O’Donnell K, Lawlor KE, Wicks IP (2001) Severe inflammatory arthritis and lymphadenopathy in the absence of TNF. J Clin Invest 107: 1519–1527PubMedGoogle Scholar
  38. 38.
    Liu Y, Wada R, Yamashita T, Mi Y, Deng CX, Hobson JP, Rosenfeldt HM, Nava VE, Chae SS, Lee MJ et al (2000) Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J Clin Invest 106: 951–961PubMedGoogle Scholar
  39. 39.
    Allende ML, Dreier JL, Mandala S, Proia RL (2004) Expression of the sphingosine 1-phosphate receptor, S1P1, on T-cells controls thymic emigration. J Biol Chem 279: 15396–15401PubMedCrossRefGoogle Scholar
  40. 40.
    Matloubian M, Lo CG, Cinamon G, Lesneski MJ, Xu Y, Brinkmann V, Allende ML, Proia RL, Cyster JG (2004) Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427: 355–360PubMedCrossRefGoogle Scholar
  41. 41.
    Brinkmann V, Davis MD, Heise CE, Albert R, Cottens S, Hof R, Bruns C, Prieschl E, Baumruker T, Hiestand P et al (2002) The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 277: 21453–21457PubMedCrossRefGoogle Scholar
  42. 42.
    Brinkmann V, Cyster JG, Hla T (2004) FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function. Am J Transplant 4: 1019–1025PubMedCrossRefGoogle Scholar
  43. 43.
    Hayry P, Mennander A, Yilmaz S, Ustinov J, Raisanen A, Miettinen A, Lautenschlager I, Lemstrom K, Bruggeman CA, Paavonen T (1992) Towards understanding the pathophysiology of chronic rejection. Clin Investig 70: 780–790PubMedCrossRefGoogle Scholar
  44. 44.
    Ross R (1999) Atherosclerosis — an inflammatory disease. N Engl J Med 340: 115–126PubMedCrossRefGoogle Scholar
  45. 45.
    Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T, Hirai H, Makuuchi M, Hirata Y, Nagai R (2002) Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 8: 403–409PubMedCrossRefGoogle Scholar
  46. 46.
    Matsumoto Y, Hof A, Baumlin Y, Muller M, Prescott MF, Hof RP (2003) Dynamics of medial smooth muscle changes after carotid artery transplantation in transgenic mice expressing green fluorescent protein. Transplantation 76: 1569–1572PubMedCrossRefGoogle Scholar
  47. 47.
    Mohrs M, Shinkai K, Mohrs K, Locksley RM (2001) Analysis of type 2 immunity in vivo with a bicistronic IL-4 reporter. Immunity 15: 303–311PubMedCrossRefGoogle Scholar
  48. 48.
    Shinkai K, Mohrs M, Locksley RM (2002) Helper T cells regulate type-2 innate immunity in vivo. Nature 420: 825–829PubMedCrossRefGoogle Scholar
  49. 49.
    Gessner A, Mohrs K, Mohrs M (2005) Mast cells, basophils, and eosinophils acquire constitutive IL-4 and IL-13 transcripts during lineage differentiation that are sufficient for rapid cytokine production. J Immunol 174: 1063–1072PubMedGoogle Scholar
  50. 50.
    Luyten M, Hofmann M, Kaeslin E, Klanke B, Pally C, Kawai R, Zerwes H (2004) A mouse model to assess endothelial activation in vivo by targeted insertion of alkaline phosphatase into the E-selecin gene. Drug Development Res 63: 54–65CrossRefGoogle Scholar
  51. 51.
    Nakajima A, Seroogy CM, Sandora MR, Tarner IH, Costa GL, Taylor-Edwards C, Bachmann MH, Contag CH, Fathman CG (2001) Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis. J Clin Invest 107: 1293–1301PubMedCrossRefGoogle Scholar
  52. 52.
    Costa GL, Sandora MR, Nakajima A, Nguyen EV, Taylor-Edwards C, Slavin AJ, Contag CH, Fathman CG, Benson JM (2001) Adoptive immunotherapy of experimental autoimmune encephalomyelitis via T cell delivery of the IL-12 p40 subunit. J Immunol 167: 2379–2387PubMedGoogle Scholar
  53. 53.
    Carlsen H, Moskaug JO, Fromm SH, Blomhoff R (2002) In vivo imaging of NF-kappa B activity. J Immunol 168: 1441–1446PubMedGoogle Scholar
  54. 54.
    Carlsen H, Alexander G, Austenaa LM, Ebihara K, Blomhoff R (2004) Molecular imaging of the transcription factor NF-kappaB, a primary regulator of stress response. Mutat Res 551: 199–211PubMedGoogle Scholar
  55. 55.
    Hardy J, Edinger M, Bachmann MH, Negrin RS, Fathman CG, Contag CH (2001) Bioluminescence imaging of lymphocyte trafficking in vivo. Exp Hematol 29: 1353–1360.PubMedCrossRefGoogle Scholar
  56. 56.
    Sadikot RT, Zeng H, Yull FE, Li B, Cheng DS, Kernodle DS, Jansen ED, Contag CH, Segal BH, Holland SM et al (2004) p47phox deficiency impairs NF-kappa B activation and host defense in Pseudomonas pneumonia. J Immunol 172: 1801–1808PubMedGoogle Scholar
  57. 57.
    Austin CP, Battey JF, Bradley A, Bucan M, Capecchi M, Collins FS, Dove WF, Duyk G, Dymecki S, Eppig JT et al (2004) The knockout mouse project. Nat Genet 36: 921–924PubMedCrossRefGoogle Scholar
  58. 58.
    Auwerx J, Avner P, Baldock R, Ballabio A, Balling R, Barbacid M, Berns A, Bradley A, Brown S, Carmeliet P et al (2004) The European dimension for the mouse genome mutagenesis program. Nat Genet 36: 925–927PubMedCrossRefGoogle Scholar

Copyright information

© Birkhäuser Verlag Basel/Switzerland 2006

Authors and Affiliations

  • Matthias Müller
    • 1
  • Nicole Avitahl-Curtis
    • 2
  1. 1.Novartis Institute of Biomedical ResearchBaselSwitzerland
  2. 2.Novartis Institute for Biomedical ResearchCambridgeUSA

Personalised recommendations